Back to last page
Health News
333
Alzheimer's
| NEW YORK (AP) -- Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.
| News brought to you by: | | |  |  | | |
|
Consumer News DMT
dmtICNNews
Consumer News DMT
161404
InteliHealth
1998-05-15
f
InteliHealth
NULL
333, 338, 341, 342, 343, 344, 411, 7087, 7228, 8009, 8010, 8011, 8012, 8013, 8014, 8015, 8895, 8896, 8988, 9247, 9254, 20774, 20775, 20776, 20778, 20779, 20780, 20783, 20785, 20786, 20789, 20792, 20833, 20938, 21142, 21291, 21343, 21344, 21345, 21928, 21961, 22002, 24129, 24524, 24603, 24644, 25491, 25886, 28041, 28042, 28043, 28815, 28918, 29758, 29783, 29796, 29806, 29823, 29834, 29848, 29852, 29861, 29866, 30961, 31307, 31406, 31438, 31464, 32054, 32143, 32212, 35038, 35178, 35428, 48607, 68682, 888341, 888342, 888343,
20774
